Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification
Sung‐Min Ahn, Se Jin Jang, Ju Hyun Shim, et al.
Hepatology (2014) Vol. 60, Iss. 6, pp. 1972-1982
Closed Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally, Miruna Balasundaram, Rebecca Carlsen, et al.
Cell (2017) Vol. 169, Iss. 7, pp. 1327-1341.e23
Open Access | Times Cited: 2121
Hepatocellular carcinoma
Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 2118
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 10, pp. 599-616
Open Access | Times Cited: 1635
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze, Sandrine Imbeaud, Éric Letouzé, et al.
Nature Genetics (2015) Vol. 47, Iss. 5, pp. 505-511
Open Access | Times Cited: 1561
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman‐Rossi, Augusto Villanueva, Jean–Charles Nault, et al.
Gastroenterology (2015) Vol. 149, Iss. 5, pp. 1226-1239.e4
Open Access | Times Cited: 1168
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero, Jessica Zucman‐Rossi
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S84-S101
Closed Access | Times Cited: 876
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Caldéraro, Gabrielle Couchy, Sandrine Imbeaud, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 727-738
Closed Access | Times Cited: 645
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet, Augusto Villanueva, Anja Lachenmayer, et al.
Nature Reviews Clinical Oncology (2015) Vol. 12, Iss. 7, pp. 408-424
Closed Access | Times Cited: 573
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J. Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 7, pp. 2116-2126
Open Access | Times Cited: 498
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou, Jean–Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 215-229
Open Access | Times Cited: 438
Molecular and histological correlations in liver cancer
Julien Caldéraro, Marianne Ziol, Valérie Paradis, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 3, pp. 616-630
Open Access | Times Cited: 435
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 404
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin Wei Tian Ng, Song Ling Poon, Mi Ni Huang, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 412
Closed Access | Times Cited: 329
Somatic mutations and clonal dynamics in healthy and cirrhotic human liver
Simon Brunner, Nicola D. Roberts, Luke A. Wylie, et al.
Nature (2019) Vol. 574, Iss. 7779, pp. 538-542
Open Access | Times Cited: 324
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 301
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
Yuan Yuan, Lingxiang Liu, Hu Chen, et al.
Cancer Cell (2016) Vol. 29, Iss. 5, pp. 711-722
Open Access | Times Cited: 294
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 286
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel, Chandra Miduturu, Michael P. Sheets, et al.
Cancer Discovery (2015) Vol. 5, Iss. 4, pp. 424-437
Open Access | Times Cited: 284
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Lulu Sun, Jie Cai, Frank J. Gonzalez
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 335-347
Closed Access | Times Cited: 283
WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation
Yiping Wang, Mengtao Xiao, Xiufei Chen, et al.
Molecular Cell (2015) Vol. 57, Iss. 4, pp. 662-673
Open Access | Times Cited: 267
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
Éric Letouzé, Jayendra Shinde, Victor Renault, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 265
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Kornelius Schulze, Jean–Charles Nault, Augusto Villanueva
Journal of Hepatology (2016) Vol. 65, Iss. 5, pp. 1031-1042
Open Access | Times Cited: 257
Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma
De‐Chen Lin, Anand Mayakonda, Huy Q. Dinh, et al.
Cancer Research (2017) Vol. 77, Iss. 9, pp. 2255-2265
Open Access | Times Cited: 186
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Renumathy Dhanasekaran, Jean–Charles Nault, Lewis R. Roberts, et al.
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 492-509
Open Access | Times Cited: 178
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Roser Pinyol, Sara Torrecilla, Huan Wang, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 865-878
Open Access | Times Cited: 178
Page 1 - Next Page

Scroll to top